The "Chromosomes 13 and 21 Test" is a specialized genetic screening conducted at DNA Labs UAE, designed to identify any abnormalities in chromosomes 13 and 21. These chromosomes are significant as their anomalies are linked to certain genetic disorders. For example, trisomy 13, also known as Patau syndrome, is associated with chromosome 13, while trisomy 21 leads to Down syndrome, related to chromosome 21. The test is crucial for early detection, allowing for better preparation and management of potential health issues associated with these chromosomal abnormalities.
DNA Labs UAE offers this testing service for a cost of 1200 AED. The lab utilizes advanced genetic testing technologies to ensure accurate and reliable results. This test is particularly recommended for expectant parents or individuals with a family history of genetic disorders. By opting for this test, one can gain valuable insights into their genetic health or that of their unborn child, facilitating informed medical and personal decisions.
The "Chromosomes 18 X and Y Test" is a specialized genetic analysis offered by DNA Labs UAE, designed to examine the chromosomes associated with determining sex (X and Y) as well as abnormalities related to chromosome 18. This test is crucial for diagnosing various genetic disorders, including but not limited to, Edwards syndrome (trisomy 18), Turner syndrome, Klinefelter syndrome, and other related conditions that can impact physical and mental development.
Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves collecting a sample of the individual's DNA through non-invasive methods, such as a blood draw or cheek swab. The laboratory then uses advanced genetic sequencing technologies to analyze the chromosomes in detail, identifying any anomalies or variations that could indicate a genetic disorder.
The cost of the "Chromosomes 18 X and Y Test" at DNA Labs UAE is set at 1200 AED. This price includes the full process of sample collection, analysis, and a comprehensive report of the findings. The report not only outlines the results but also provides insights and recommendations for further action if any abnormalities are detected. This test is a valuable tool for individuals seeking to understand their genetic health, especially for prospective parents concerned about inherited genetic conditions.
Cord blood, the blood that remains in the umbilical cord and placenta post-delivery, is a rich source of stem cells and genetic material. It is increasingly being utilized for karyotyping tests, which are critical in identifying chromosomal abnormalities in newborns. These tests can detect a wide range of genetic disorders and conditions, such as Down syndrome, Turner syndrome, and Klinefelter syndrome, among others. Conducting a karyotyping test on cord blood offers a non-invasive method to obtain valuable genetic information about the newborn shortly after birth.
At DNA Labs UAE, a leading facility in genetic testing, the karyotyping test using cord blood is available for 1200 AED. This test provides parents and healthcare professionals with essential insights into the baby's genetic health, enabling early intervention and management of potential genetic conditions. The cost of the test includes the collection of cord blood at the time of birth, processing, and detailed analysis by expert geneticists. DNA Labs UAE is equipped with state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of test results, making it a trusted choice for genetic testing services in the region.
The "Cystic Fibrosis Mutation Screening CFTR - Del 508 Test" is a specialized genetic test conducted to identify the presence of the most common mutation, ΔF508 (delta F508), in the CFTR gene associated with cystic fibrosis (CF). This mutation leads to the production of a defective protein that affects the movement of salt and water in and out of cells, resulting in thick, sticky mucus in the lungs, digestive tract, and other areas of the body. Cystic fibrosis is a hereditary disorder characterized by severe damage to the respiratory and digestive systems.
The test involves analyzing a small sample of blood or saliva to check for the ΔF508 mutation. It is crucial for early diagnosis, allowing for timely intervention and management of the disease. This test is particularly recommended for individuals with a family history of cystic fibrosis or partners of people with cystic fibrosis who are considering starting a family.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test cost is set at 1200 AED. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable test results, providing essential information for affected individuals and their families to manage the condition effectively.
The Immunohistochemistry Pituitary Adenoma Panel Test is a specialized diagnostic procedure aimed at identifying pituitary adenomas, which are benign tumors of the pituitary gland. This test utilizes immunohistochemistry (IHC) techniques to detect specific markers that are commonly expressed in pituitary adenoma cells. By applying antibodies that bind to these markers, the test can highlight the presence and extent of tumor cells within a tissue sample, providing valuable information on the type and possibly the behavior of the adenoma.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, this test is crucial for accurately diagnosing pituitary adenomas, thereby guiding appropriate treatment strategies. The cost of the Immunohistochemistry Pituitary Adenoma Panel Test at DNA Labs UAE is 1520 AED. This investment is essential for patients presenting symptoms of pituitary disorders, as it facilitates a targeted approach to treatment, potentially improving patient outcomes.
The Kappa Lambda Light Chains Free Serum Test is a specialized diagnostic procedure aimed at measuring the levels of free kappa and lambda light chains in the serum. These light chains are part of immunoglobulins (antibodies) produced by plasma cells. The balance and ratio of kappa to lambda light chains are crucial for assessing various conditions, including multiple myeloma, a type of blood cancer, and other disorders related to the immune system.
This test is particularly useful for the early detection, monitoring, and evaluation of treatment response in patients with plasma cell disorders or other related diseases. By analyzing the free light chains in the serum, healthcare providers can gain valuable insights into the disease's progression and the effectiveness of the treatment being administered.
At DNA Labs UAE, the Kappa Lambda Light Chains Free Serum Test is available for 1520 AED. The facility ensures precise and reliable testing services, utilizing advanced technologies and methodologies under the supervision of experienced professionals. Test results are provided with accuracy and speed, aiding in the timely diagnosis and management of conditions associated with abnormal levels of kappa and lambda light chains.
The Kappa Lambda Light Chains Free Urine Test is a specialized diagnostic procedure performed to measure the levels of free kappa and lambda light chains in the urine. These light chains are small proteins produced by plasma cells, a type of white blood cell. Normally, kappa and lambda light chains are produced in a relatively balanced ratio. However, certain conditions, such as multiple myeloma and other disorders of the plasma cells, can disrupt this balance, leading to an excess production of one type of light chain. The test is crucial for the diagnosis and monitoring of these conditions, providing vital information about the disease's progression and the patient's response to treatment.
At DNA Labs UAE, the test is conducted with precision and accuracy, utilizing advanced technology to ensure reliable results. The cost of the Kappa Lambda Light Chains Free Urine Test is set at 1520 AED. This investment in health allows patients to access a crucial diagnostic tool that can significantly impact their treatment plan and overall well-being. DNA Labs UAE is known for its commitment to providing high-quality diagnostic services, making it a trusted choice for patients and healthcare providers seeking comprehensive health assessments.
The LPL Expert Breast Cancer Panel Test is a specialized genetic test available at DNA Labs UAE, designed to identify specific mutations in genes associated with an increased risk of developing breast cancer. This test plays a crucial role in the early detection and prevention of breast cancer by providing individuals with vital information about their genetic predisposition to the disease. By analyzing DNA samples, the panel can pinpoint mutations in the LPL gene, among others, that are linked to breast cancer, enabling healthcare professionals to tailor personalized prevention and treatment plans for their patients. The cost of the LPL Expert Breast Cancer Panel Test at DNA Labs UAE is 1520 AED, making it an accessible option for those seeking to understand their genetic risk factors for breast cancer. This test is particularly recommended for individuals with a family history of breast cancer or other related cancers, as it can provide peace of mind or guide in taking proactive measures towards health management.
The Multiple Sclerosis Panel 1 Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect biomarkers associated with Multiple Sclerosis (MS), a chronic autoimmune disease that affects the central nervous system. Priced at 1520 AED, this test aims to provide critical insights into the genetic predisposition and immune system irregularities linked to MS, facilitating early detection and personalized treatment strategies. By analyzing specific genetic markers and immune responses, the test can help healthcare professionals tailor interventions and monitor disease progression, offering hope for better management of this complex condition.
Myotonic Dystrophy Type 2, also known as DM2 or proximal myotonic myopathy (PROMM), is a genetic disorder characterized by muscle weakness and myotonia, which is an inability to relax muscles at will. This condition varies in its presentation and severity, affecting not only the muscles but potentially also the heart, endocrine system, and central nervous system. Unlike Myotonic Dystrophy Type 1, DM2 tends to have a later onset and often presents milder symptoms.
To diagnose Myotonic Dystrophy Type 2, a specific genetic test is conducted to identify the presence of a mutation in the CNBP (ZNF9) gene, which is the hallmark of DM2. This mutation involves an expansion of a CCTG repeat in the gene. The genetic test for DM2 is crucial for accurate diagnosis, guiding treatment options, and providing information on the genetic risk for family members.
In the United Arab Emirates, DNA Labs UAE offers a comprehensive testing service for Myotonic Dystrophy Type 2. The test is priced at 1520 AED, reflecting the specialized nature of the genetic analysis. Conducted in a state-of-the-art laboratory by skilled geneticists, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for the specific genetic mutation associated with DM2.
Upon completion, the test provides individuals and their healthcare providers with crucial information regarding the diagnosis, allowing for a better understanding of the condition and the development of a tailored management plan. This can include strategies to manage symptoms, monitor potential complications, and offer genetic counseling for affected individuals and their families.
